CClinicalTrials.gg
Sign In
Not yet recruitingNCT06601894Updated Oct 4, 2024

The Relationship of Platelet Counts With Sickle Cell Anemia in the Eastern Region of Saudi Arabia

An observational study in Sickle Cell Anaemia and SCD, sponsored by Majmaah University. Not yet recruiting at 1 site in Saudi Arabia. Open to participants aged 1 Year and older. Per ClinicalTrials.gov, last updated 2024-10-04.

Sponsored by Majmaah University · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 9 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
650
Ages
1 Year and older
Sex
All
01

Study summary

This study aims to evaluate the relationship between platelet counts and sickle cell disease in the eastern region of the Kingdom of Saudi Arabia.

Read the detailed description

Introduction:

This study aims to evaluate the relationship between platelet counts and sickle cell disease in the eastern region of the Kingdom of Saudi Arabia.

Purpose: This study aims to assess the prevalence and factors associated with elevated platelet counts in people with sickle cell disease in the eastern region of Saudi Arabia.

Methods: This cross-sectional study at Majmaah University will analyze prerecorded data frfom the eastern region of Saudi Arabia to investigate the relationship between platelet counts and sickle cell disease, identifying associated factors and assessing the link .

Importance: To assess the relationship between platelet counts and disease severity in Pationt with SCD.

Aim :To investigate the relationship between platelet counts and SCD in the eastern region of the Kingdom of Saudi Arabia.

02

Conditions studied

  • Sickle Cell Anaemia
  • SCD
03

In context

Anemia

1,733 studies on the registry are indexed under Anemia; 246 are open to participants now.

This study's planned enrollment of 650 is above the median of 200 across 326 observational studies indexed under Anemia.

Browse Anemia studies →

Lead sponsor

Majmaah University is the lead sponsor of 24 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

The study will include a cohort of people with SCD who are registered at the Hereditary Blood center al-ahssa.

Eligibility criteria

Inclusion criteria: All the diagnosed patients of sickle cell disease regardless of age and gender.

Exclusion criteria: Patients without having sickle cell disease regardless of age and gender.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
650 participants (estimated)
Target follow-up
1 Month
Patient registry
Yes

Groups and cohorts

  • Males

    The study will be conducted on CBC count special PLT for adult Males of different ages with sickle cell anemia.

    Diagnostic Test: Platelets count

  • Children

    The study will be conducted on CBC count special PLT for adult Males of different ages with sickle cell anemia.

    Diagnostic Test: Platelets count

  • Females

    The study will be conducted on CBC count special PLT for adult Males of different ages with sickle cell anemia.

    Diagnostic Test: Platelets count

Interventions

  • Diagnostic testPlatelets count

    the study include will take medical investigation data for all sickle cell patients.

06

What researchers measure

Primary outcomes

  1. Collecting platelet data for sickle cell anemia patients

    Collecting platelet data for sickle cell anemia patients in males and female and children based on different ages, then analyzing them and studying their relationship

    Time frame: From January 2023 to December 2023

07

Study locations

1 site
  • Khalid Ali Majrashi
    Dammam, Saudi Arabia
    • MOHAMMED A Eidaroos, PHD · Contact · m.alaidarous@mu.edu.sa · 0164042900
    • KHALID A MAJRASHI · Principal investigator
08

References and documents

Publications

  • Wun T, Paglieroni T, Rangaswami A, Franklin PH, Welborn J, Cheung A, Tablin F. Platelet activation in patients with sickle cell disease. Br J Haematol. 1998 Mar;100(4):741-9. doi: 10.1046/j.1365-2141.1998.00627.x. PubMed 9531343 ↗
  • Shome DK, Jaradat A, Mahozi AI, Sinan AS, Ebrahim A, Alrahim M, Ebraheem MS, Mansoor EJ, Majed KS, Azeez Pasha SA. The Platelet Count and its Implications in Sickle Cell Disease Patients Admitted for Intensive Care. Indian J Crit Care Med. 2018 Aug;22(8):585-590. doi: 10.4103/ijccm.IJCCM_49_18. PubMed 30186009 ↗
  • Yee MEM, Batsuli G, Chonat S, Park S. Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease. Clin Case Rep. 2020 Nov 20;9(1):457-460. doi: 10.1002/ccr3.3556. eCollection 2021 Jan. PubMed 33489197 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06601894
Lead sponsor
Majmaah University
Responsible party
Khalid Ali Majrashi (Student, Majmaah University) — Principal investigator
First posted
Sep 19, 2024
Start date
Dec 1, 2024 (estimated)
Primary completion
Dec 31, 2024 (estimated)
Completion
Mar 30, 2025 (estimated)
Last update
Oct 4, 2024

Study contacts

Khalid A Majrashi
Contact
khalid77555@hotmail.com
0533489978
Khalid A Majrashi
principal investigator · Majmaah University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Anemia→

Other studies from this sponsor

Majmaah University

Start the discussion